Market News / Story
Caribou Biosciences, Inc. Stock 12‑Month Price Target Raised to $11, Implies 869% Upside
·
According to estimates from 5 analysts, Caribou Biosciences, Inc. stock's average price target has risen from $10 to $11, with forecasts ranging from $1 to $32 per share Based on the Oct. 6 closing price, the updated target implies approximately 869% potential upside Consensus rating remains at “Buy” across 5 covering analysts, with 3 Buys, 2 Holds and 0 Sells Explore more price target data and ratings for Caribou Biosciences, Inc. on the Forecasts tab , and track all…